Doctor profile · Federal record

Dr. Francisco Bautista Vitiello, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Student in an Organized Health Care Education/Training Program · Charlotte, NC

  • NPI 1992078901
  • Accepts Medicare
  • 19 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
6060 Piedmont Row Dr S Fl 6
Charlotte, NC 282873884
(704) 489-3094
Mailing address
5960 Fairview RD Ste 500
Charlotte, NC 282103113

Credentials & registration

NPPES · NUCC
NPI registered
February 2012 — 14 yrs on file
Profile last updated
May 9, 2025
Year of graduation
2007 — 19 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
North Carolina #2017-01048
Medicaid
NC #1992078901

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1992078901. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
9,571
Distinct HCPCS
10
Medicare allowed
$294,175
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 7,620 80 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 500 320 $123
83036 Hemoglobin a1c level 210 119 $9
96372 Injection of drug or substance under skin or into muscle 172 86 $14
80053 Blood test, comprehensive group of blood chemicals 165 131 $10
84443 Blood test, thyroid stimulating hormone (tsh) 163 115 $16
84439 Thyroxine (thyroid chemical), free 155 109 $9
82306 Vitamin d-3 level 110 90 $29
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 89 43 $33
76536 Ultrasound scan of head and neck soft tissue 81 80 $107

In context: peer comparison

Among 15 peers in this city , average services per provider: 321. This provider delivers 30× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$686
Transactions
33
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Lilly USA, LLC 6 $126.26
IBSA Pharma Inc. 4 $74.82
Novo Nordisk Inc 4 $72.22
SANOFI-AVENTIS U.S. LLC 3 $60.43
Radius Health, Inc. 2 $53.92
Amgen Inc. 2 $44.35
Amneal Pharmaceuticals LLC 2 $42.84
Corcept Therapeutics 2 $33.48
Bayer Healthcare Pharmaceuticals Inc. 2 $32.89
Abbott Laboratories 1 $28.79
Esperion Therapeutics, Inc. 1 $28.07
Novartis Pharmaceuticals Corporation 1 $23.74
Ascendis Pharma Inc 1 $18.74
Xeris Pharmaceuticals, Inc. 1 $16.50
ABBVIE INC. 1 $14.60

By nature of payment

Food and Beverage
$686

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,223
Patients
700
Total drug cost
$1,017,932
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 299 94 $5,728
Metformin Hcl Er (Metformin Hcl) Brand 272 104 $4,068
Glimepiride Generic 210 69 $1,679
Trulicity (Dulaglutide) Brand 200 38 $302,292
Ozempic (Semaglutide) Brand 154 35 $244,020
Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) Brand 151 53 $131,305
Metformin Hcl Generic 147 54 $2,242
Pioglitazone Hcl Generic 141 50 $1,914
Methimazole Generic 130 33 $1,554
Alendronate Sodium Generic 117 40 $1,176

Frequently asked questions

Auto-generated from federal data
What is Dr. Francisco Bautista Vitiello's medical specialty?
Dr. Francisco Bautista Vitiello practices Endocrinology, Diabetes & Metabolism Physician in Charlotte, NC.
Where does Dr. Francisco Bautista Vitiello practice?
Dr. Francisco Bautista Vitiello practices at 6060 Piedmont Row Dr S Fl 6, Charlotte, NC 282873884. Office phone: 7044893094.
What is Dr. Francisco Bautista Vitiello's NPI?
Dr. Francisco Bautista Vitiello's National Provider Identifier (NPI) is 1992078901, issued by NPPES.
Does Dr. Francisco Bautista Vitiello accept Medicare assignment?
Yes. Dr. Francisco Bautista Vitiello accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Francisco Bautista Vitiello commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Hemoglobin a1c level (HCPCS 83036). Source: CMS Medicare Physician & Other Practitioners file.